CYT387 Inhibits the Hyperproliferative Potential of Fibroblast-like Synoviocytes via Modulation of IL-6/JAK1/STAT3 Signaling in Rheumatoid Arthritis

References

• Abubaker K, Luwor RB, Escalona R, McNally O, Quinn MA, Thompson EW, Findlay JK, Ahmed N. 2014. Targeted disruption of the JAK2/STAT3 pathway in combination with systemic administration of paclitaxel inhibits the priming of ovarian cancer stem cells leading to a reduced tumor burden. Front Oncol. 4:75.
   PubMedGoogle Scholar
• Ahmad SF, Ansari MA, Nadeem A, Zoheir KM, Bakheet SA, Alsaad AM, Al-Shabanah OA, Attia SM. 2017. STA-21, a STAT-3 inhibitor, attenuates the development and progression of inflammation in collagen antibody-induced arthritis. Immunobiology. 222(2):206–17.
   PubMed Web of Science ®Google Scholar
• Ahn JK, Oh JM, Lee J, Bae EK, Ahn KS, Cha HS, Koh EM. 2010. Increased extracellular survivin in the synovial fluid of rheumatoid arthritis patients: fibroblast-like synoviocytes as a potential source of extracellular survivin. Inflammation. 33(6):381–88.
   PubMed Web of Science ®Google Scholar
• Bakheet SA, Alrwashied BS, Ansari MA, Nadeem A, Attia SM, Alanazi MM, Aldossari AA, Assiri MA, Mahmood HM, Al-Mazroua HA, et al. 2020a. CXC chemokine receptor 3 antagonist AMG487 shows potent anti-arthritic effects on collagen-induced arthritis by modifying B cell inflammatory profile. Immunol Lett. 225:74–81.
   PubMed Web of Science ®Google Scholar
• Bakheet SA, Alrwashied BS, Ansari MA, Nadeem A, Attia SM, Assiri MA, Alqahtani F, Ibrahim KE, Ahmad SF. 2020b. CXCR3 antagonist AMG487 inhibits glucocorticoid-induced tumor necrosis factor-receptor-related protein and inflammatory mediators in CD45 expressing cells in collagen-induced arthritis mouse model. Int Immunopharmacol. 84:106494.
   PubMed Web of Science ®Google Scholar
• Bakheet SA, Ansari MA, Nadeem A, Attia SM, Alhoshani AR, Gul G, Al-Qahtani QH, Albekairi NA, Ibrahim KE, Ahmad SF. 2019. CXCR3 antagonist AMG487 suppresses rheumatoid arthritis pathogenesis and progression by shifting the Th17/Treg cell balance. Cell Signal. 64:109395.
   PubMed Web of Science ®Google Scholar
• Bokarewa M, Andersson K, Erlandsson M, Svensson M, Cavallini N, Brisslert M. 2015. Survivin co-ordinates formation of follicular T-cells in rheumatoid arthritis. Arth Rheumatol. 6(24):20043.
   Google Scholar
• Bottini N, Firestein GS. 2013. Duality of fibroblast-like synoviocytes in RA: passive responders and imprinted aggressors. Nat Rev Rheumatol. 9(1):24.
   PubMed Web of Science ®Google Scholar
• Chamberlain ND, Vila OM, Volin MV, Volkov S, Pope RM, Swedler W, Mandelin AM, Shahrara S. 2012. TLR5, a novel and unidentified inflammatory mediator in rheumatoid arthritis that correlates with disease activity score and joint TNF-α levels. J Immunol. 189(1):475–83.
   PubMed Web of Science ®Google Scholar
• Chen D, Zeng S, Huang M, Xu H, Liang L, Yang X. 2017. Role of protein arginine methyltransferase 5 in inflammation and migration of fibroblast-like synoviocytes in rheumatoid arthritis. J Cell Mol Med. 21(4):781–90.
   PubMed Web of Science ®Google Scholar
• Cohen SB, Van Vollenhoven RF, Winthrop KL, Zerbini CA, Tanaka Y, Bessette L, Zhang Y, Khan N, Hendrickson B, Enejosa JV, et al. 2020. Safety profile of upadacitinib in rheumatoid arthritis: integrated analysis from the SELECT phase III clinical programme. Ann Rheum Dis. 80(3):304–11.
   PubMed Web of Science ®Google Scholar
• Collison J. 2019. Placental growth factor links angiogenesis and autoimmunity. Nat Rev Rheumatol. 15(10):575.
   PubMed Web of Science ®Google Scholar
• Croker BA, Krebs DL, Zhang JG, Wormald S, Willson TA, Stanley EG, Robb L, Greenhalgh CJ, Förster I, Clausen BE, et al. 2003. SOCS3 negatively regulates IL-6 signaling in vivo. Nat Immunol. 4(6):540–45.
   PubMed Web of Science ®Google Scholar
• Deng J, Fan C, Gao X, Zeng Q, Guo R, Wei Y, Chen Z, Chen Y, Gong D, Feng J, et al. 2018. Signal transducer and activator of transcription 3 hyperactivation associates with follicular helper T cell differentiation and disease activity in rheumatoid arthritis. Front Immunol. 9:1226.
   PubMed Web of Science ®Google Scholar
• Fan T, Zhang C, Zong M, Fan L. 2018. Hypoxia-induced autophagy is inhibited by PADI4 knockdown, which promotes apoptosis of fibroblast-like synoviocytes in rheumatoid arthritis. Mol Med Rep. 17(4):5116–24.
   PubMed Web of Science ®Google Scholar
• Firestein GS. 1999. Starving the synovium: angiogenesis and inflammation in rheumatoid arthritis. J Clin Investig. 103(1):3–4.
   PubMed Web of Science ®Google Scholar
• Ganesan R, Rasool M. 2019. Ferulic acid inhibits interleukin 17-dependent expression of nodal pathogenic mediators in fibroblast-like synoviocytes of rheumatoid arthritis. J Cell Biochem. 120(2):1878–93.
   PubMed Web of Science ®Google Scholar
• Genovese MC, Kremer JM, Van Vollenhoven RF, Alten R, Scali JJ, Kelman A, Dimonaco S, Brockwell L. 2017. Transaminase levels and hepatic events during tocilizumab treatment: pooled analysis of long-term clinical trial safety data in rheumatoid arthritis. Arth Rheumatol. 69(9):1751–61.
   PubMed Web of Science ®Google Scholar
• He L, Qin Q, He J, Wang H, Hu Y, He W, Xu B, Zhou G, Shan H, Yang B, et al. 2020. ErMiao san inhibits angiogenesis in rheumatoid arthritis by suppressing JAK/STAT signaling pathways. Evid-Based Complemen Altern Med. Article ID 4381212. doi:10.1155/2020/4381212
   Google Scholar
• Ikari Y, Isozaki T, Tsubokura Y, Kasama T. 2019. Peficitinib inhibits the chemotactic activity of monocytes via proinflammatory cytokine production in rheumatoid arthritis fibroblast-like synoviocytes. Cell. 8(6):561.
   PubMed Web of Science ®Google Scholar
• Jia W, Wu W, Yang D, Xiao C, Huang M, Long F, Su Z, Qin M, Liu X, Zhu YZ. 2018. GATA4 regulates angiogenesis and persistence of inflammation in rheumatoid arthritis. Cell Death Dis. 9(5):1–5.
   PubMedGoogle Scholar
• Kim JW, Kong JS, Lee S, Yoo SA, Koh JH, Jin J, Kim WU. 2020. Angiogenic cytokines can reflect the synovitis severity and treatment response to biologics in rheumatoid arthritis. Exp Mol Med. 52(5):843–53.
   PubMed Web of Science ®Google Scholar
• Kim NH, Lee MY, Park SJ, Choi JS, Oh MK, Kim IS. 2007. Auranofin blocks interleukin-6 signalling by inhibiting phosphorylation of JAK1 and STAT3. Immunol. 122(4):607–14.
   PubMed Web of Science ®Google Scholar
• Konisti S, Kiriakidis S, Paleolog EM. 2012. Hypoxia—a key regulator of angiogenesis and inflammation in rheumatoid arthritis. Nat Rev Rheumatol. 8(3):153.
   PubMed Web of Science ®Google Scholar
• Li GQ, Liu D, Zhang Y, Qian YY, Zhu YD, Guo SY, Sunagawa M, Hisamitsu T, Liu YQ. 2013. Anti-invasive effects of celastrol in hypoxia-induced fibroblast-like synoviocyte through suppressing of HIF-1α/CXCR4 signaling pathway. Int Immunopharmacol. 17(4):1028–36.
   PubMed Web of Science ®Google Scholar
• Miao P, Zhou XW, Wang P, Zhao R, Chen N, Hu CY, Chen XH, Qian L, Yu QW, Zhang JY, et al. 2018. Regulatory effect of anti-gp130 functional mAb on IL-6 mediated RANKL and Wnt5a expression through JAK-STAT3 signaling pathway in FLS. Oncotarget. 9(29):20366.
   PubMedGoogle Scholar
• Migita K, Izumi Y, Jiuchi Y, Kozuru H, Kawahara C, Izumi M, Sakai T, Nakamura M, Motokawa S, Nakamura T, et al. 2014. Effects of J anus kinase inhibitor tofacitinib on circulating serum amyloid A and interleukin-6 during treatment for rheumatoid arthritis. Clin Exp Immunol. 175(2):208–14.
   PubMed Web of Science ®Google Scholar
• Pope J, Sawant R, Tundia N, Du EX, Qi CZ, Song Y, Tang P, Betts KA. 2020. Comparative efficacy of JAK inhibitors for moderate-to-severe rheumatoid arthritis: a network meta-analysis. Adv Ther. 37(5):2356.
   PubMed Web of Science ®Google Scholar
• Ridgley LA, Anderson AE, Maney NJ, Naamane N, Skelton AJ, Lawson CA, Emery P, Isaacs JD, Carmody RJ, Pratt AG. 2019. IL-6 mediated transcriptional programming of naïve CD4+ T cells in early rheumatoid arthritis drives dysregulated effector function. Front.immunol. 10:1535.
   PubMed Web of Science ®Google Scholar
• Rose-John S. 2012. IL-6 trans-signaling via the soluble IL-6 receptor: importance for the proinflammatory activities of IL-6. Int J Biol Sci. 8(9):1237.
   PubMed Web of Science ®Google Scholar
• Shankar J, Thippegowda PB, Kanum SA. 2009. Inhibition of HIF-1α activity by BP-1 ameliorates adjuvant induced arthritis in rats. Biochem Biophysics Res Commun. 387(2):223–28.
   PubMed Web of Science ®Google Scholar
• Shi R, Chen M, Litifu B, Zhaorigetu. 2018. Serum interleukin-6 and survivin levels predict clinical response to etanercept treatment in patients with established rheumatoid arthritis. Mod Rheumatol. 28(1):126–32.
   PubMed Web of Science ®Google Scholar
• Smolen JS, Xie L, Jia B, Taylor PC, Burmester G, Tanaka Y, Elias A, Cardoso A, Ortmann R, Walls C, et al. 2020. Efficacy of baricitinib in patients with moderate-to-severe rheumatoid arthritis with 3 years of treatment: results from a long-term study. Rheumatol. 79:1.
   Google Scholar
• Tas SW, Maracle CX, Balogh E, Szekanecz Z. 2016. Targeting of proangiogenic signalling pathways in chronic inflammation. Nat Rev Rheumatol. 12(2):111.
   PubMed Web of Science ®Google Scholar
• Tyner JW, Bumm TG, Deininger J, Wood L, Aichberger KJ, Loriaux MM, Druker BJ, Burns CJ, Fantino E, Deininger MW. 2010. CYT387, a novel JAK2 inhibitor, induces hematologic responses and normalizes inflammatory cytokines in murine myeloproliferative neoplasms. Blood. 115(25):5232–40.
   PubMed Web of Science ®Google Scholar
• Uson J, Balsa A, Pascual-Salcedo D, Cabezas JA, Gonzalez-Tarrio JM, Martin-Mola E, Fontan G. 1997. Soluble interleukin 6 (IL-6) receptor and IL-6 levels in serum and synovial fluid of patients with different arthropathies. J Rheumatol. 24(11):2069.
   PubMed Web of Science ®Google Scholar
• Winton EF, Kota V. 2017. Momelotinib in myelofibrosis: JAK1/2 inhibitor with a role in treating and understanding the anemia. Future Oncol. 13(5):395–407.
   PubMed Web of Science ®Google Scholar
• Yoo SA, Kwok SK, Kim WU. 2008. Proinflammatory role of vascular endothelial growth factor in the pathogenesis of rheumatoid arthritis: prospects for therapeutic intervention. Mediators Inflamm. 2008:1–6.
   Web of Science ®Google Scholar
• Zafari P, Rafiei A, Esmaeili SA, Moonesi M, Taghadosi M. 2019. Survivin a pivotal antiapoptotic protein in rheumatoid arthritis. J Cell Physiol. 234(12):21575–87.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Ren G, Guo M, Ye X, Zhao J, Xu L, Qi J, Kan F, Liu M, Li D. 2013. Synergistic effects of interleukin-1β and interleukin-17A antibodies on collagen-induced arthritis mouse model. Int Immunopharmacol. 15(2):199–205.
   PubMed Web of Science ®Google Scholar